163 related articles for article (PubMed ID: 20571059)
1. Reversal of TNP-470-induced endothelial cell growth arrest by guanine and guanine nucleosides.
Hines J; Ju R; Dutschman GE; Cheng YC; Crews CM
J Pharmacol Exp Ther; 2010 Sep; 334(3):729-38. PubMed ID: 20571059
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1.
Zhang Y; Griffith EC; Sage J; Jacks T; Liu JO
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6427-32. PubMed ID: 10841547
[TBL] [Abstract][Full Text] [Related]
3. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).
Kusaka M; Sudo K; Matsutani E; Kozai Y; Marui S; Fujita T; Ingber D; Folkman J
Br J Cancer; 1994 Feb; 69(2):212-6. PubMed ID: 8297716
[TBL] [Abstract][Full Text] [Related]
4. The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest.
Yeh JR; Mohan R; Crews CM
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12782-7. PubMed ID: 11070090
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO
Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784
[TBL] [Abstract][Full Text] [Related]
6. Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer.
Nahari D; Satchi-Fainaro R; Chen M; Mitchell I; Task LB; Liu Z; Kihneman J; Carroll AB; Terada LS; Nwariaku FE
Mol Cancer Ther; 2007 Apr; 6(4):1329-37. PubMed ID: 17431111
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 murine melanoma cell line.
Okrój M; Kamysz W; Slominska EM; Mysliwski A; Bigda J
Anticancer Drugs; 2005 Sep; 16(8):817-23. PubMed ID: 16096429
[TBL] [Abstract][Full Text] [Related]
8. The fumagillin analogue TNP-470 inhibits DNA synthesis of vascular smooth muscle cells stimulated by platelet-derived growth factor and insulin-like growth factor-I. Possible involvement of cyclin-dependent kinase 2.
Koyama H; Nishizawa Y; Hosoi M; Fukumoto S; Kogawa K; Shioi A; Morii H
Circ Res; 1996 Oct; 79(4):757-64. PubMed ID: 8831499
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470.
Mori J; Haisa M; Naomoto Y; Takaoka M; Kimura M; Yamatsuji T; Notohara K; Tanaka N
Jpn J Cancer Res; 2000 Jun; 91(6):643-50. PubMed ID: 10874218
[TBL] [Abstract][Full Text] [Related]
10. Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression.
Turk BE; Su Z; Liu JO
Bioorg Med Chem; 1998 Aug; 6(8):1163-9. PubMed ID: 9784858
[TBL] [Abstract][Full Text] [Related]
11. Participation of cyclin D1 deregulation in TNP-470-mediated cytostatic effect: involvement of senescence.
Lien WH; Chen CK; Lai LY; Chen YH; Wu MP; Wu LW
Biochem Pharmacol; 2004 Aug; 68(4):729-38. PubMed ID: 15276080
[TBL] [Abstract][Full Text] [Related]
12. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2.
Mori S; Yoshikawa H; Hashimoto J; Ueda T; Funai H; Kato M; Takaoka K
Bone; 1998 Feb; 22(2):99-105. PubMed ID: 9477232
[TBL] [Abstract][Full Text] [Related]
15. Plausible novel therapeutic strategy of uterine endometrial cancer with reduction of basic fibroblast growth factor secretion by progestin and O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470).
Fujimoto J; Hori M; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
Cancer Lett; 1997 Feb; 113(1-2):187-94. PubMed ID: 9065821
[TBL] [Abstract][Full Text] [Related]
16. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of tumor angiogenesis.
Taki T; Ohnishi T; Arita N; Hiraga S; Saitoh Y; Izumoto S; Mori K; Hayakawa T
J Neurooncol; 1994; 19(3):251-8. PubMed ID: 7807176
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
[TBL] [Abstract][Full Text] [Related]
19. TNP-470 promotes initial vascular sprouting in xenograft tumors.
Huang J; Frischer JS; New T; Kim ES; Serur A; Lee A; Kadenhe-Chiwishe A; Pollyea DA; Yokoi A; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
Mol Cancer Ther; 2004 Mar; 3(3):335-43. PubMed ID: 15026554
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma.
Xia JL; Yang BH; Tang ZY; Sun FX; Xue Q; Gao DM
J Cancer Res Clin Oncol; 1997; 123(7):383-7. PubMed ID: 9260590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
